VCU Massey Cancer Center

Menu

Massey awarded American Cancer Society Institutional Research Grants for more than four decades

David Gewirtz, Ph.D.

VCU Massey Cancer Center was recently awarded an Institutional Research Grant (IRG) from the American Cancer Society. Massey has continuously been awarded an  ACS IRG for more than four decades. The latest IRG (18-159-43), totaling $350,000 in direct costs over the course of three years, will provide separate block grants for early career investigators pursuing cancer research.

David A. Gewirtz, Ph.D., has served as the grant’s principal investigator for the last 13 years and leads Massey’s ACS-IRG review committee, which annually allocates seed funding to the cancer center’s beginning investigators.

“We are very grateful to the American Cancer Society for their continued recognition of our efforts to support the research of our junior faculty members through the awarding of this grant,” said Gewirtz, member of the Developmental Therapeutics research program at Massey and professor of pharmacology, toxicology and medicine at the VCU School of Medicine. “Not only does this funding allow these researchers to generate preliminary data that will be used as a foundation for submission of extramural grant applications to organizations such as the National Institutes of Health, but the feedback that the applicants receive from the reviews of their ACS-IRG grant submissions provides guidance to improve their grant writing skills.”

Grant applications are currently being accepted at Massey until February 1, 2019, from junior faculty for the award of small research grants of up to $30,000 for one year to perform basic, pre-clinical, clinical and cancer control research studies.

“We are pleased to renew this longstanding collaboration with VCU through the IRG,” said William Phelps, Ph.D., American Cancer Society Senior Vice President of Extramural Research.   “Partnerships like these, which leverage our combined resources to support beginning cancer researchers, are essential to achieving our goal to end cancer.” 

Recent Massey junior investigators at Massey who have received individual funding through the ACS-IRG include, among others, Jennifer Rohan, Ph.D., to study predictors of nonadherence to oral medications in pediatric cancer; Paula Bos, Ph.D., to investigate a specific class of protein’s dependency on the antitumor effects of regulatory T-cells; and TaeHo Kim, Ph.D., to study the application of 4D magnetic resonance imaging in cancer radiotherapy.

Written by: Blake Belden

Posted on: January 17, 2019